Document |
Document Title |
WO/2024/088792A1 |
The present invention relates to the strobilurin type compounds of formula I and the N-oxides and the salts thereof and their use for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytoch...
|
WO/2024/059287A3 |
An orally ingestible contraceptive composition for a pig or rodent is provided. The exemplary composition comprises 0.005 to 1.4 wt. % free gossypol and non-free-gossypol matter. The non-free-gossypol matter comprises a bulk feed compone...
|
WO/2024/089225A1 |
The present invention provides, inter alia, a process for preparing a compound of formula (I) wherein the substituents are as defined in claim 1.
|
WO/2024/071178A1 |
Provided is an industrially useful method for producing an alkylsilyloxy-substituted benzylamine compound, in which impurities are easily removed and the method does not involve an alkylsilyloxy-substituted benzyl compound that is an int...
|
WO/2024/061348A1 |
The present invention provides a 1,3-cyclohexanedione compound shown in formula I, and a stereoisomer and an agrochemically acceptable salt thereof, wherein R1, R2, R3, and R4 are as defined in the description. Also disclosed are a prepa...
|
WO/2024/056678A1 |
The present invention relates to compounds according to formula (I), which are prodrugs of the psychoactive compound phenethylamine or its derivatives. The prodrugs provided herein exhibit improved pharmacokinetic properties during uptak...
|
WO/2024/043108A1 |
A photocurable composition containing a coloring agent, a radical polymerization initiator represented by formula (1) and a radically polymerizable compound; a method for producing a cured film using the photocurable composition; a film;...
|
WO/2024/038436A1 |
The present invention relates to the preparation of cyantraniliprole, comprising the preparation of 8-methyl-2,4-dioxo-l,4-dihydro-2H-benzo[d][l,3]oxazine-6-car
bonitrile key intermediate via 2-amino-5-((hydroxyimino)methyl)-3-methylbenz...
|
WO/2024/031002A1 |
This disclosure includes pesticidal compounds, compositions, and related agricultural methods.
|
WO/2023/244862A1 |
In one aspect, aryl carboximidamide compounds, comprising a carboximidamide molecular substructure, and modulating mammalian sirtuin enzymes (SIRT1-7) are described herein, and, in particular, to compounds for the modulation of SIRT3. No...
|
WO/2023/236809A1 |
The present invention belongs to the technical field of anti-inflammatory drugs. Disclosed are a 2,6-dibenzylidene cyclohexanone oxime compound, a method for preparing same, and use thereof. According to the present invention, a structur...
|
WO/2023/221868A1 |
Provided in the present invention are a derivative of an isoxazoline compound and the use thereof in the prevention and treatment of parasitic infections. The derivative of the isoxazoline compound has the following general structural fo...
|
WO/2023/196616A1 |
The present disclosure is directed to the synthesis and application of novel compounds having unique and desired flavor and/or fragrance characteristics. The compounds of the present disclosure can be employed alone or incorporated as fr...
|
WO/2023/178266A2 |
The present disclosure relates to fluorinated phenylamino compounds, their pharmaceutical compositions, and methods for treating one or more tumors or cancers selected from the group consisting of plexiform neurofibromas (PN), plexiform ...
|
WO/2023/144798A1 |
Certain embodiments of the invention provide ionizable lipids having optimized clearance properties. Certain embodiments of the invention also provide nucleic acid-lipid particles comprising ionizable lipids, methods of making the lipid ...
|
WO/2023/135341A1 |
The invention relates to a urease inhibiting composition containing at least one of the compounds of formulas (I), (II) and (III) or a combination thereof: 1,4-dihydroxy-3,6-diisobutylpiperazine-2,5-dione (I), 2-[(N-hydroxyleucyl)-imino]...
|
WO/2023/133875A1 |
Provided is a multifunctional group metal corrosion inhibitor, as shown in one or more of formula (I-a) to formula (I-c). The metal corrosion inhibitor is a multifunctional group metal corrosion inhibitor comprising Schiff base or a deri...
|
WO/2023/124970A1 |
Disclosed are a cyclic 1,3-diketodiimine compound with a symmetrical structure, a synthesis method and use thereof. The compound has a structure represented by the following general formula (III), (II), or (III): wherein R1-R5 are each i...
|
WO/2023/125001A1 |
A cyclic 1,3-diketonediimine compound, and a synthesis method therefor and the use thereof. The cyclic 1,3-diketonediimine compound has a structure as shown in the following general formulas I, II or III, wherein R1-R8 are each independe...
|
WO/2023/112722A1 |
The present invention addresses the problem of providing: a compound suitably used for forming an optical anisotropic membrane that has excellent reverse wavelength dispersion property and moist heat durability; a polymerizable compositi...
|
WO/2023/104616A1 |
The invention relates to a novel method for producing isoxazolinecarboxylic acid derivatives of formula (I).
|
WO/2023/101319A1 |
The present invention relates to a method for preparing an oxime derivative more easily by using a nitrogen oxide as a NO supply source under mild conditions.
|
WO/2023/097386A1 |
The present invention relates to selective HDAC6-inhibiting N-acylhydrazone compounds. More specifically, the present invention relates to N-acylhydrazone compounds of formula (I), and to the methods for producing same, compositions, kit...
|
WO/2023/097259A1 |
The invention discloses novel RAR gamma selective agonists used in the treatment of cancer. The invention also discloses administration of RAR gamma selective agonists to mammals, including humans for the purpose of selectively activatin...
|
WO/2023/082149A1 |
The present disclosure relates to novel intermediates, preparation process thereof, and a process for producing isofetamid. The present disclosure also relates to the use of novel intermediates for preparing isofetamid. The present discl...
|
WO/2023/085056A1 |
An embodiment of the present invention provides: a curable composition comprising a radical polymerization initiator represented by formula 1 and a radically polymerizable compound; a method for producing a cured product of the curable c...
|
WO/2023/074527A1 |
The present invention addresses the problem of providing: a crystalline composition comprising a benzoxazine compound represented by general formula (1); and a method for producing same. As a solution, provided is a crystalline compositi...
|
WO/2023/072670A1 |
The present invention relates to the use of strobilurin type compounds of formula I and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b ...
|
WO/2023/060811A1 |
Disclosed in the present invention are a fluralaner intermediate and a method for preparing fluralaner thereby. The fluralaner intermediate-5 is aaa. A synthetic route comprises: using m-xylene as a starting raw material, performing halo...
|
WO/2023/044343A1 |
The present disclosure details various lipids, compositions, and/or methods of optimized systems and delivery vehicles for the delivery of nucleic acid sequences, polypeptides or peptides for use in vaccinating against infectious agents.
|
WO/2023/285883A1 |
Disclosed herein are embodiments of a bi-functionalized dicyclopentadiene monomer and polymer embodiments formed therefrom. The monomer embodiments exhibit tunability and can be used to form thermally stable homopolymers, copolymers, and...
|
WO/2023/280630A1 |
The present invention relates to a process for the preparation of substituted amidoximes of formula I, which can be obtained through reaction of nitrile compounds of formula II with free hydroxylamine in the presence of a solvent.
|
WO/2023/279773A1 |
Provided are a preparation method for a tedizolid intermediate represented by formula (I), and an intermediate. The method comprises: 1) reacting 2-fluoro-4-substituted phenylacetic acid with a Vilsmeier reagent, and then adding a reacti...
|
WO/2023/279205A1 |
The present technology relates to UV radiation-absorbing and/or visible radiation-absorbing compounds, and use of same in the preparation of compositions for protecting biological and nonbiological material against UV and/or visible radi...
|
WO/2023/275221A1 |
The present invention relates to metal complexes and their use as metal oxide precursors for optical and microelectronic applications. The metal complexes comprise one or more metals M selected from V, Nb and Ta and one or more organic o...
|
WO/2022/261956A1 |
It is described the use of a compound according to formula (I) as precursor in perfumery for generating a ketone or aldehyde of formula (II).
|
WO/2022/257957A1 |
The present invention relates to a use of γ,δ-unsaturated oxime ester compounds of formula (I) as photoinitiators, wherein variables are as defined in the description. The present invention further relates to a preparation method for t...
|
WO/2022/249003A1 |
The present invention relates to an improved process for the preparation of intermediate of Trifloxystrobin in single isolation stage. The present invention provides an improved process for the preparation of (E)-2-(2-halomethylphenyl)-2...
|
WO/2022/227923A1 |
The present invention belongs to the field of organic synthesis, and particularly relates to a hexadecane tromethamine compound. The compound comprises the following structural formula (I). Also provided are a synthesis method therefor a...
|
WO/2022/207428A1 |
A compound (1), (2), (3), (4), (5), (6), (7), or (8); and double bond regioisomers thereof.
|
WO/2022/207427A1 |
A compound of formula (I)(I).
|
WO/2022/193368A1 |
The present invention belongs to the technical field of medicinal chemistry, and disclosed are a trans-amantadine derivative or a salt thereof, and a preparation method therefor, a composition thereof and the use thereof. Provided in the...
|
WO/2022/193369A1 |
The present invention relates to the technical field of pharmaceutical chemistry. Disclosed is a use of a trans amantadine derivative having a structure as represented by formula I or a pharmaceutically acceptable salt thereof in the pre...
|
WO/2022/187271A1 |
Compound formulations include gadusol or gadusporine that can be used as topicals, such as sunscreens or filters that protect human and animal skin against harmful light like UVA, and UVB, cosmetics, and skin care products. In some examp...
|
WO/2022/181793A1 |
The present invention provides: a compound that is represented by formula (1) (in the formula, the combination of X and L represents a combination or the like in which X is a nitrogen atom and L is an oxygen atom or NH, n represents 1 or...
|
WO/2022/174628A1 |
The invention relates to a method for co-producing adipic acid and cyclohexanone oxime from cyclohexane. The method comprises: (1) subjecting cyclohexane and NO x to oxidation nitration to generate adipic acid, nitrocyclohexane, a nitrog...
|
WO/2022/163708A1 |
Provided is a fluorine-containing ether compound represented by the following formula. R1-R2-CH2-R3-CH2-R4 (wherein R1 is a terminal group that includes an oxime group and is represented by formula (2), R2 is a divalent linking...
|
WO/2022/158993A1 |
The present invention relates to a method for the production of d-erythro-sphingosine and analogs thereof, wherein the method comprises a step of condensing a compound of formula (2): Formula (2), or a salt thereof, wherein R1 is hydroge...
|
WO/2022/149459A1 |
A non-linear optical absorption material according to an aspect of the present disclosure contains, as a main component, a compound represented by formula (1). In formula (1), R1 to R27 contain, independently of each other, at least one ...
|
WO/2022/149460A1 |
A light-absorbing material in one embodiment of the present disclosure contains, as a main component, the compound represented by formula 1 below. In formula 1, R1 through R28 contain, independently from one another, at least one atom se...
|